These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36719881)

  • 21. Pharmacological interventions for treating intrahepatic cholestasis of pregnancy.
    Walker KF; Chappell LC; Hague WM; Middleton P; Thornton JG
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD000493. PubMed ID: 32716060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of cholestasis on absorption of ursodeoxycholic acid.
    Sauer P; Benz C; Rudolph G; Klöters-Plachky P; Stremmel W; Stiehl A
    Dig Dis Sci; 1999 Apr; 44(4):817-22. PubMed ID: 10219843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficiency of ursodeoxycholic acid for the treatment of nonalcoholic steatohepatitis: A systematic review and meta-analysis.
    Lin X; Mai M; He T; Huang H; Zhang P; Xia E; Guo H
    Expert Rev Gastroenterol Hepatol; 2022 Jun; 16(6):537-545. PubMed ID: 35617696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corticotropin-releasing hormone expression in patients with intrahepatic cholestasis of pregnancy after ursodeoxycholic acid treatment: an initial experience.
    Zhou F; Zhang L; He MM; Liu ZF; Gao BX; Wang XD
    Curr Med Res Opin; 2014 Aug; 30(8):1529-35. PubMed ID: 24665980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal cardiac dysfunction in intrahepatic cholestasis of pregnancy is associated with elevated serum bile acid concentrations.
    Vasavan T; Deepak S; Jayawardane IA; Lucchini M; Martin C; Geenes V; Yang J; Lövgren-Sandblom A; Seed PT; Chambers J; Stone S; Kurlak L; Dixon PH; Marschall HU; Gorelik J; Chappell L; Loughna P; Thornton J; Pipkin FB; Hayes-Gill B; Fifer WP; Williamson C
    J Hepatol; 2021 May; 74(5):1087-1096. PubMed ID: 33276032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a short-term, randomized, double-blind controlled, cross-over study with long-term follow up.
    Hwang SJ; Chan CY; Lee SD; Wu JC; Tsay SH; Lo KJ
    J Gastroenterol Hepatol; 1993; 8(3):217-23. PubMed ID: 8100153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of ursodeoxycholic acid in patients with cholestasis of pregnancy].
    Palma J; Reyes H; Ribalta J; Iglesias J; González M; Hernández I; Alvarez C; Molina C; Danitz AM
    Rev Med Chil; 1991 Feb; 119(2):169-71. PubMed ID: 1824160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.
    Bacq Y; Sentilhes L; Reyes HB; Glantz A; Kondrackiene J; Binder T; Nicastri PL; Locatelli A; Floreani A; Hernandez I; Di Martino V
    Gastroenterology; 2012 Dec; 143(6):1492-501. PubMed ID: 22892336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ursodeoxycholic acid for primary biliary cirrhosis.
    Gong Y; Huang ZB; Christensen E; Gluud C
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000551. PubMed ID: 18677775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimum dose of ursodeoxycholic acid in primary biliary cirrhosis.
    Verma A; Jazrawi RP; Ahmed HA; Davis T; Bland JM; Benson M; Orchard RT; Theodossi A; Maxwell JD; Northfield TC
    Eur J Gastroenterol Hepatol; 1999 Oct; 11(10):1069-76. PubMed ID: 10524634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ursodeoxycholic acid administration on bile duct proliferation and cholestasis in bile duct ligated rat.
    Frezza EE; Gerunda GE; Plebani M; Galligioni A; Giacomini A; Neri D; Faccioli AM; Tiribelli C
    Dig Dis Sci; 1993 Jul; 38(7):1291-6. PubMed ID: 8325189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ursodeoxycholic acid use is associated with significant risk of morbidity and mortality in infants with cholestasis: A strobe compliant study.
    Kotb MA; Mosallam D; Basanti CWS; El Sorogy STM; Badr AM; Abd El Baky HEH; Draz IH
    Medicine (Baltimore); 2020 Feb; 99(7):e18730. PubMed ID: 32049781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is ursodeoxycholic acid detrimental in obstructive cholestasis? A propos of a case of malignant biliary obstruction.
    Bessone F; Roma MG
    Ann Hepatol; 2016; 15(3):442-7. PubMed ID: 27049500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of ursodeoxycholic acid in patients with severe obstructive jaundice after drainage procedure.
    Hsu SH; Lu CL; Chan CY; Lin SH; Chang FY; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Sep; 60(3):142-6. PubMed ID: 9419950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of chronic liver disease with ursodeoxycholic acid.
    Guslandi M
    J Int Med Res; 1990; 18(6):497-505. PubMed ID: 2292332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventive effect of ursodeoxycholic acid on parenteral nutrition-associated liver disease in infants.
    Simić D; Milojević I; Bogićević D; Milenović M; Radlović V; Drasković B; Benka AU; Sindjić S; Maksimović R
    Srp Arh Celok Lek; 2014; 142(3-4):184-8. PubMed ID: 24839773
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ursodeoxycholic acid increases differentiation and mineralization and neutralizes the damaging effects of bilirubin on osteoblastic cells.
    Dubreuil M; Ruiz-Gaspà S; Guañabens N; Peris P; Alvarez L; Monegal A; Combalia A; Parés A
    Liver Int; 2013 Aug; 33(7):1029-38. PubMed ID: 23560764
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ileal absorption of bile acids in patients with chronic cholestasis: SeHCAT test results and effect of ursodeoxycholic acid (UDCA).
    Chazouillères O; Marteau P; Haniche M; Jian R; Poupon R
    Dig Dis Sci; 1996 Dec; 41(12):2417-22. PubMed ID: 9011452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ursodeoxycholic acid versus placebo in the treatment of women with intrahepatic cholestasis of pregnancy (ICP) to improve perinatal outcomes: protocol for a randomised controlled trial (PITCHES).
    Chappell LC; Chambers J; Dixon PH; Dorling J; Hunter R; Bell JL; Bowler U; Hardy P; Juszczak E; Linsell L; Rounding C; Smith A; Williamson C; Thornton JG
    Trials; 2018 Nov; 19(1):657. PubMed ID: 30482254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized trial in primary biliary cirrhosis comparing ursodeoxycholic acid in daily doses of either 10 mg/kg or 20 mg/kg. Dutch Multicentre PBC Study Group.
    Van Hoogstraten HJ; De Smet MB; Renooij W; Breed JG; Engels LG; Den Ouden-Muller JW; Rijk MC; Smit AM; Zwertbroek R; Hop WC; van Berge Henegouwen GP; Schalm SW; van Buuren HR
    Aliment Pharmacol Ther; 1998 Oct; 12(10):965-71. PubMed ID: 9798800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.